Cargando…
Osimertinib-induced Keratitis and Secondary Toxic Epidermal Necrotic Drug Eruption- A Case Report and Literature Review
BACKGROUND: Osimertinib is a third-generation Tyrosine Kinase inhibitor, mainly used in non-small cell lung cancer with EGFR mutation. Its efficacy and safety have been confirmed by clinical practice. Toxic epidermolysis necrotizing disease (TEN) is a severe drug eruption that is rare in clinics and...
Autores principales: | Xu, Yunhua, Li, Yong, Luo, Jie, Tang, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680087/ https://www.ncbi.nlm.nih.gov/pubmed/37254553 http://dx.doi.org/10.2174/1574886318666230529123200 |
Ejemplares similares
-
Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
por: Lampert, Anette, et al.
Publicado: (2023) -
Analysis of Intoxication, Rehospitalization, and One-year Survival of Heart Failure Patients Receiving Digoxin at Harapan Kita National Cardiovascular Center, Jakarta, Indonesia: A Cross Section-observational Study
por: Nafrialdi, Nafrialdi, et al.
Publicado: (2023) -
Drug-induced Sudden Death: A Scoping Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2023) -
Multidrug Resistance-1 C3435T Polymorphism and Carbamazepine Plasma Level in Indonesian Temporal Lobe Epilepsy Patients
por: Budikayanti, Astri, et al.
Publicado: (2023) -
Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
por: Xin, Zhijun, et al.
Publicado: (2023)